Hem/Onc Roundup: Lung Cancer Screenings Decline, Insurance Status Linked to Myeloma Survival, and More

Study: Lung Cancer Screening Amid the COVID-19 Pandemic

A review found a decline in lung cancer screening, but an overall rise in malignancies since the COVID-19 pandemic. In this study, researchers compared monthly visits for low-dose computed tomography screening for lung cancer during the three months of COVID-19 restrictions. The article appeared in Journal of the American College of Surgeons. 

Study: Lung Cancer Screening Amid the COVID-19 Pandemic

Vitamin D Deficiency Linked to Pancreatic Cancer Survival

Vitamin D deficiency prior to cancer treatment is associated with increased inflammation and shorter overall survival in patients with pancreatic cancer. Across all disease stages, vitamin D-deficient patients had the highest median levels of inflammatory biomarkers compared with the other groups. Patients with stage I or II disease and vitamin D deficiency also had a higher hazard ratio for mortality.

Vitamin D Deficiency Linked to Pancreatic Cancer Survival

Insurance Status Linked to Survival for Patients with Multiple Myeloma

Insurance status was found to be significantly associated with survival for patients with multiple myeloma (MM), according to a study presented at the 2020 American Society of Hematology Annual Meeting & Exposition. Researchers analyzed data from 41,846 adults with a primary diagnosis of MM and found that five-year survival was significantly lower in patients with Medicaid insurance compared with privately insured patients.

Insurance Status Linked to Survival for Patients with Multiple Myeloma

Patients Undergoing Head and Neck Cancer Surgery Have a Low Risk of COVID-19 Infection

Patients undergoing head and neck cancer surgery do not have an increased risk of SARS-CoV-2 (COVID-19) infection, according to a study published in the journal CANCER. In this study, researchers assessed data on 1,137 patients with head and neck cancer undergoing potentially curative surgery in 26 countries. According to the results, the death rate within 30 days after surgery was just over 1%, a rate that would be normally expected in this patient population, without a pandemic.

Patients Undergoing Head and Neck Cancer Surgery Have a Low Risk of COVID-19 Infection